Equities

Midday Report: Verve (VERV) Gains on September 28


Shares of Verve Therapeutics Inc (NASDAQ: VERV) are up 10.05% Wednesday.



As of 19:00:00 est, Verve sits at $0.00 and has climbed $3.13 per share in trading so far.



Verve has moved 12.60% over the last 30 days and has a YTD change of 7.02% based on the most recent close.



The company is set to release earnings on 2022-11-10.



For technical charts, analysis, and more on Verve visit the company profile.







To get more information on Verve Therapeutics Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Verve Therapeutics Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Fix from Equities News to receive the best stories to your inbox.



Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Bond Yields Have Risen Well Above Stock Dividend Yields. Are They a Buy?
We’re at the Tail End of a Classic Video Game Stock Bust
Is Gold Really the Right Place for Your Money?
How Companies Can Succeed in AI Winter: Jeff Kagan
Utility Investing Is a Steady, Buy-and-Hold Play. Just Not in This Market
Why Nuclear Energy Is Now Part of The Road to Renewables
Our Inflation Nightmare Will Flatline in Six Months
California Wants 100% Electric Vehicles By 2035. Will Its Energy Grid Be Ready?





Source link

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button